Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease

Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease

Takeda’s Replagal (agalsidase alfa) or Sanofi Genzyme’s Fabrazyme (agalsidase beta) – for at least three years and on a stable dose administered every two weeks.

Latest news

More from news
Approximately 18 fully matching, plus 73 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    One example is Genzyme (now Sanofi Genzyme), a pioneer in the rare disease space with a focus on R&D efforts targeting enzyme replacement therapies for lysosomal storage disorders and leading ... including Shire/Takeda, Actelion/J&J, Sanofi Genzyme,

  • Case study: See Below Case study: See Below

    Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme

  • Case study: OptiMiSe for MS nurses Case study: OptiMiSe for MS nurses

    Client:Sanofi Genzyme. Agency:Vivid – A Lucid Group Company. Campaign:OptiMiSe for MS nurses: a tailored, added-value support service for clinical behaviour change towards optimised services. ... It has also resulted in Sanofi Genzyme SOM-led support

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.

  • Case study: The World vs MS Case study: The World vs MS

    Client:Sanofi Genzyme. Agency:H4B Manchester. Campaign:The World vs MS. Timescale:Ongoing. The World vs MS is an ongoing, ambitious social movement that has united the world in the fight ... As the world’s first pharma-sponsored emoji, it reinforces

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics